NHS National Pharmaceuticals Transition 2022_2
Invitation to offer for NHS National Pharmaceuticals Transition 2022_2 Offer reference number: CM/PHG/22/5655 Period of framework agreement: Dates detailed below, with an option or options to extend (at the discretion of the Authority) up to maximum contract length of 48 months. Potential periods of call-offs under the framework agreement: Transition: CESW: 01/12/2022 to 30/09/2023 (10 months) LSNE: 01/12/2022 to 31/05/2024 (18 months) NWLN: 01/12/2022 to 31/05/2023 (6 months)
Buyer
NHS England
Value
£35,745,737
Published
4 Nov 2022
Closes
23 Aug 2022
Procurement details
Source
Contracts Finder
Region
London
Procurement method
Open
Category
Goods
Contract starts
1 Dec 2022
Contract ends
31 May 2024
CPV classifications
33600000
Pharmaceutical products
Lots
Lot default NHS National Pharmaceuticals Transition 2022_2
£35,745,737
Invitation to offer for NHS National Pharmaceuticals Transition 2022_2 Offer reference number: CM/PHG/22/5655 Period of framework agreement: Dates detailed below, with an option or options to extend (at the discretion of the Authority) up to maximum contract length of 48 months. Potential periods of call-offs under the framework agreement: Transition: CESW:...
Delivery: East Midlands · United Kingdom, East of England · United Kingdom, Guernsey, Isle of Man, Jersey, London · United Kingdom
Documents
Unlock document linkAwarded contract notice on Contracts Finder
4 Nov 2022
Awarded contract notice on Contracts Finder
Award notice · Web page
Transition 2022_2 Transparency Award Schedules
Not provided
Transition 2022_2 Transparency Award Schedules
Parties Appointed to Framework Agreement and SME Status - Tranasition 2022_2
Not provided
Parties Appointed to Framework Agreement and SME Status - Tranasition 2022_2
Excel spreadsheet
Transition 2022_2 Framework Agreement and Terms and Conditions
Not provided
Transition 2022_2 Framework Agreement and Terms and Conditions
Contains public sector information licensed under the Open Government Licence v3.0.